Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

HARTE HANKS INC (HHS)

21 + Investors. Track Smart Money conviction in HHS. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -2
Streak
1Q ▼
Buyers last Q
47%

Smart Money Signals — HHS

Based on 21 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their HHS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 75% of 3.0Y peak

75% of all-time peak
21 funds currently hold this stock — 75% of the 3.0-year high of 28 funds (reached 2024 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 9% fewer funds vs a year ago

fund count last 6Q
2 fewer hedge funds hold HHS compared to a year ago (-9% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 47% buying

7 buying8 selling
Last quarter: 8 funds reduced or exited vs 7 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~2 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 3 → 4 → 2 → 2. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

76% of holders stayed for 2+ years

76% conviction (2yr+) 10% medium 14% new
16 out of 21 hedge funds have held HHS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +0%, value -25%

Value
-25%
Shares
+0%
Last quarter: funds added +0% more shares while total portfolio value only changed -25%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
⚠️

Saturation — most institutions already know this story

3 → 3 → 4 → 2 → 2 new funds/Q
New funds entering each quarter: 3 → 4 → 2 → 2. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🏛️

Deep conviction — 76% of holders stayed 2+ years

76% veterans 5% 1-2yr 19% new
Of 21 current holders: 16 (76%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 8% AUM from top-100

8% from top-100 AUM funds
8 of 21 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
2.3
out of 10
Low Exit Risk
Exit risk score 2.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — HHS

In 2026 Q1, 7 hedge funds were net buyers of HHS (2 opened a new position, 5 added to an existing one), while 8 reduced or exited (4 trimmed, 4 sold completely) — a 47% buyer ratio, indicating roughly balanced activity. Net fund flow last quarter: -2 funds (more exits than new entries). Total institutional holders: 21.

Hedge Fund Ownership: HHS

How many hedge funds hold HHS — quarterly history vs. share price
Quarterly hedge fund ownership of HHS vs. share price

Market Analysis: HHS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: HHS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy HARTE HANKS INC (HHS) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much HHS has moved relative to its sector benchmark (XLI) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 71d ago
HHS
+9.1%
XLI
+4.9%

HHS outperformed XLI by +4.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 26d ago
HHS
-12.1%
XLI
+3988.2%

Since the filing became public, HHS outperformed XLI by -4000.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.2
/ 10
conviction
Hedge Fund Positioning: HHS
21 + Investors

Track Smart Money conviction in HHS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 21 23 -8.7%
13F Shares 2M 2M 0.02%
Total Value $5M $6M -25.21%
New Positions 2 2 -
Increased Positions 5 4 +1
Closed Positions 4 2 +2
Reduced Positions 4 8 -4
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: HHS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

21 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in HHS. Verified SEC 13F-HR filings.

QUARTER:
Top 18 institutional holders of HHS — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 WESTERLY CAPITAL MANAGEMENT, LLC 0.39% 627,000 $1.4M
2 RAFFLES ASSOCIATES LP 0.17% 87,757 $199K
3 Krilogy Financial LLC 0.01% 118,175 $339K
4 BLAIR WILLIAM & CO/IL 0.00% 660,845 $1.5M
5 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% 32,600 $74K
6 Tower Research Capital LLC (TRC) 0.00% 1,995 $5K
7 ACADIAN ASSET MANAGEMENT LLC 0.00% 32,547
8 RENAISSANCE TECHNOLOGIES LLC 0.00% 22,200 $50K
9 LSV ASSET MANAGEMENT 0.00% 12,700
10 Triumph Capital Management 0.00% 86
11 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.00% 17,204 $39K
12 VANGUARD FIDUCIARY TRUST CO 0.00% 30,619 $70K
13 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 259,036 $588K
14 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% 17,623 $40K
15 BlackRock, Inc. 0.00% 28,861 $66K
16 UBS Group AG 0.00% 207
17 MORGAN STANLEY 0.00% 7
18 WELLS FARGO & COMPANY/MN 0.00% 1
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — HARTE HANKS INC (HHS)

What does the Smart Money Trend signal show for HHS?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their HHS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for HHS?

More sellers than buyers — 47% buying: Last quarter: 8 funds reduced or exited vs 7 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for HHS holders?

Smaller funds dominant — 8% AUM from top-100: 8 of 21 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held HHS?

76% of holders stayed for 2+ years: 16 out of 21 hedge funds have held HHS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy HARTE HANKS INC (HHS) following the 2026 Q1 hedge fund 13F filings?

As of today, HHS has moved -12.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3988.2% for the XLI sector ETF — an outperformance of -4000.3%. Since the quarter end (March 31, 2026), HHS has gained +9.1% vs +4.9% for XLI. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →